Sertoli cell

Sertoli cells are a type of sustentacular "nurse" cell found in human testes which contribute to the process of spermatogenesis (the production of sperm) as a structural component of the seminiferous tubules. They are activated by follicle-stimulating hormone (FSH) secreted by the adenohypophysis and express FSH receptor on their membranes.

Germinal epithelium of the testicle.
1. basal lamina
2. spermatogonia
3. primary (1st-order) spermatocyte
4. secondary (2nd-order) spermatocyte
5. developing spermatid
6. mature spermatid
7. Sertoli cell
8. tight junction (blood-testis barrier)
Histological section through testicular parenchyma of a boar.
1. lumen of Tubulus seminiferus contortus
2. spermatids
3. spermatocytes
4. spermatogonia
5. Sertoli cell
6. myofibroblasts
7. Leydig cells
8. capillaries
Details
SystemReproductive system
LocationTestes
FunctionAssist in the production of sperm
Identifiers
MeSHD012708
FMA72298
Anatomical terms of microanatomy

History

Sertoli cells are named after Enrico Sertoli, an Italian physiologist who discovered them while studying medicine at the University of Pavia, Italy.[1] He published a description of his eponymous cell in 1865.[2] The cell was discovered by Sertoli with a Belthle microscope which had been purchased in 1862. In the 1865 publication, his first description used the terms "tree-like cell" or "stringy cell"; most importantly, he referred to these as "mother cells". Other scientists later used Enrico's family name to label these cells in publications, beginning in 1888. As of 2006, two textbooks that are devoted specifically to the Sertoli cell have been published.

Structure

Sertoli cells are specifically located in the convolutions of the seminiferous tubules, since this is the only place in the testes where spermatozoa are produced. As the primary support cell of the tubules, they are generally very large and amorphous, with individual cells stretching from the basal lamina to the lumen; their cytoplasm often completely surrounds the germline cells which they are responsible for nursing. Sertoli cells are easily confused with the other cells of the germinal epithelium when using standard staining techniques; the most distinctive feature of the Sertoli cell is its dark nucleolus.[3]

Development

Sertoli cells are required for male sexual development. Sertoli cell proliferation and differentiation is mainly activated by FGF9, with which they also form a feedforward loop.[4][5] It has been suggested that Sertoli cells may derive from the fetal mesonephros.[6] After puberty, Sertoli cells begin to elongate. Their nucleoli become larger and tight junctions are completed, creating a fluid-filled lumen space.[7]

FSH is responsible for controlling the proliferation of Sertoli cells shortly after birth and stimulates the production of factors derived from Sertoli cells that control the development of the testes and germ cells. FSH, luteinizing hormone. thyroid-stimulating hormone, and hCG are all known to affect Sertoli cell development and male reproductive health. FSH is required for Sertoli cell mitogen, which stimulates the expression of various cell markers.[7]

Once fully differentiated, the Sertoli cell is considered terminally differentiated, and is unable to proliferate.[8] Therefore, once spermatogenesis has begun, no more Sertoli cells are created, and their population within the seminiferous tubules is finite.

Recently, however, scientists have found a way to induce Sertoli cells to a juvenile proliferative phenotype outside of the body.[9] This gives rise to the possibility of repairing some defects of testicular niche cells which may cause male infertility.

Function

Because its main function is to nourish developing sperm cells through the stages of spermatogenesis, the Sertoli cell has also been called the "mother" or "nurse" cell.[10] Sertoli cells also act as phagocytes, consuming the residual cytoplasm during spermatogenesis. Translocation of cells from the basal lamina to the lumen of the seminiferous tubules occurs by conformational changes in the lateral margins of the Sertoli cells.

Secretory

Sertoli cells secrete the following substances:

Structural

The occluding junctions of Sertoli cells form the blood-testis barrier, a structure that partitions the interstitial blood compartment of the testis from the adluminal compartment of the seminiferous tubules. Because of the apical progression of the spermatogonia, the occluding junctions must be dynamically reformed and broken to allow the immunoidentical spermatogonia to cross through the blood-testis barrier so that they can become immunologically unique. Sertoli cells control the entry and exit of nutrients, hormones, and other chemicals into the tubules of the testis as well as make the adluminal compartment an immune-privileged site.

Sertoli cells are also responsible for establishing and maintaining the spermatogonial stem cell niche, which ensures the renewal of stem cells and the differentiation of spermatogonia into mature germ cells that progress stepwise through the long process of spermatogenesis, ending in the release of spermatozoa in a process known as spermiation.[13] Sertoli cells bind to spermatogonial cells via N-cadherins and galactosyltransferase (via carbohydrate residues).

Other functions

During spermatogenesis, Sertoli cells provide nutrition to the spermatogonia.

Sertoli cells are capable of repairing DNA damage.[14] This repair likely employs the process of non-homologous end joining involving XRCC1 and PARP1 proteins that are expressed in Sertoli cells.[14]

Sertoli cells have a higher mutation frequency than spermatogenic cells.[15] Compared to spermatocytes, the mutation frequency is about 5 to 10-fold higher in Sertoli cells. This may reflect the need for greater efficiency of DNA repair and mutation avoidance in the germ line than in somatic cells.

Immunomodulatory properties of Sertoli cells

Besides expressing factors that are crucial for sperm cell maturation, Sertoli cells also produce a wide range of molecules (either on their surface or soluble) that are able to modify the immune system. The ability of Sertoli cells to change the immune response in the tubule is needed for successful sperm cell maturation. Sperm cells express neo-epitopes on their surface as they progress through different stages of maturation, which can trigger a strong immune response if placed in a different part of the body.

Molecules produced by Sertoli cells associated with immunosuppression or immunoregulation

FAS/FAS-L system – expression of Fas ligand (Fas-L) on the surface of SCs activates apoptotic death of Fas receptor-bearing cells, e.g. cytotoxic T cells.[16]

- soluble FasL: increasing the effectivity of the system

- soluble Fas: FasL blockage on the surface of other cells (no apoptotic induction in Sertoli cells by immune cells)

B7/H1 – decreasing proliferation of effector T-cells[17]

Jagged1 (JAG1) – induction of Foxp3 transcription factor expression in naive T lymphocytes (increasing relative numbers of T regulatory cells)[18]

Protease inhibitor-9 (PI-9) – member of serpin family (serine protease inhibitors),[19] which induces secretion of protease Granzyme B, cytotoxic T-cells and NK cells are able to induce apoptosis in target cell. SCs produce PI-9 that irreversibly bonds Granzyme B and inhibits its activity.

CD59, a surface molecule on SCs and a member of the complement regulatory proteins (CRP), inhibits the last step of the complement cascade, the formation of the membrane attack complex.[20]

Clusterin, a soluble molecule with functions similar to CD59, forms a complex with Granzyme B and inhibits activation of apoptosis by T-lymphocytes or NK cells.[20]

TGF-beta, a transforming growth factor beta (its direct production by SCs is controversial), contributes to the induction of regulatory T-cells on the periphery.[21]

Other molecules

CD40, a molecule associated with dendritic cells (DCs). SCs are able to down regulate the expression of CD40 on the surface of DCs, by an unknown mechanism. Downregulation of CD40 results in the decreased ability of DCs to stimulate the T-cell response.[20]

Sertoli cells are also able to inhibit the migration of immune cells by lowering immune cell infiltration to the site of inflammation.

Clinical significance

Sertoli-Leydig cell tumour is part of the sex cord-stromal tumour group of ovarian neoplasms. These tumors produce both Sertoli and Leydig cells and lead to an increased secretion of testosterone in ovaries and testicles.

Other animals

Cross-section of a seminiferous tubule of the testis of a rat (250x)

The function of Sertoli cells in the Amniota and Anamniota is the same, but they have slightly different properties when compared to each other. Anamnionts (fish and amphibians) employ cystic spermatogenesis in order to produce sperm cells.[22] In the Amniota, Sertoli cells are terminally differentiated cells which are normally incapable of proliferating. In the Anamniota, Sertoli cells go through two proliferative phases. The first phase of proliferation occurs during cyst establishment, promoting the migration of germ cells into it.[23][24] The second phase involves enlargement of the cyst which produces space for the proliferating germ cells.[25]

The once commonly accepted fact that Sertoli cells are unable to divide and proliferate in Amniota has recently been challenged. Upon xenogenic transplantation, Sertoli cells have been shown to regain the ability to proliferate.[26]

Research

Recently (2016), experimental models of autoimmune inflammatory disorders, including diabetes, have prompted the implication of Sertoli cells into cell therapy transplantation thanks to their immunoregulatory and anti-inflammatory properties.[27]

Research into adapting Sertoli cells for use in the treatment of type I diabetes mellitus involves the strategy of cotransplanting β cells together with Sertoli cells into the recipient organism. In mice, rats, and humans, the presence of these cells restored glucose homeostasis as well as lowered requirements for external insulin. In all cases no immunosuppression was used, and the role of this medication was taken and provided by SC.[28][29][30]

By treating spontaneously diabetic and obese mice with the transplantation of microencapsulated Sertoli cells in subcutaneous abdominal fat deposits, Giovanni et al.[27] demonstrated that more than half of the treated mice showed improved glucose homeostasis. This recent scientific work promises a future better treatment to patients with type 2 diabetes mellitus through the use of cell therapy.

Sertoli cells promote skin graft acceptance by the recipient organism[31] and their presence also helps to increase the numbers of motor neurons in the spinal cord of SOD1 mice (a mouse model used in the study of amyotrophic lateral sclerosis).[32]

See also

References

  1. synd/518 at Who Named It?
  2. Sertoli, Enrico (1865). "Dell'esistenza di particolari cellule ramificate nei canalicoli seminiferi del testicolo umano" [On the existence of particular ramified cells in the seminiferous canaliculi of the human testis]. Il Morgagni (in Italian). 7: 31–40.
  3. OSU Center for Veterinary Health Sciences - OSU-CVHS Home Archived 2006-12-09 at the Wayback Machine
  4. Kim Y, Kobayashi A, Sekido R, DiNapoli L, Brennan J, Chaboissier MC, Poulat F, Behringer RR, Lovell-Badge R, Capel B (June 2006). "Fgf9 and Wnt4 act as antagonistic signals to regulate mammalian sex determination". PLOS Biology. 4 (6): e187. doi:10.1371/journal.pbio.0040187. PMC 1463023. PMID 16700629.
  5. Moniot B, Declosmenil F, Barrionuevo F, Scherer G, Aritake K, Malki S, Marzi L, Cohen-Solal A, Georg I, Klattig J, Englert C, Kim Y, Capel B, Eguchi N, Urade Y, Boizet-Bonhoure B, Poulat F (June 2009). "The PGD2 pathway, independently of FGF9, amplifies SOX9 activity in Sertoli cells during male sexual differentiation". Development. 136 (11): 1813–21. doi:10.1242/dev.032631. PMC 4075598. PMID 19429785.
  6. Vize PD, Woolf AS, Bard J (2003). The kidney: from normal development to congenital disease. Academic Press. pp. 82–. ISBN 978-0-12-722441-1. Retrieved 18 November 2010.
  7. Shah, W; Khan, R; Shah, B; Khan, A; Dil, S; Liu, W; Wen, J; Jiang, X (2021). "The Molecular Mechanism of Sex Hormones on Sertoli Cell Development and Proliferation". Frontiers in Endocrinology. 12: 648141. doi:10.3389/fendo.2021.648141. PMC 8344352. PMID 34367061.
  8. Sharpe RM, McKinnell C, Kivlin C, Fisher JS (June 2003). "Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood". Reproduction. 125 (6): 769–84. doi:10.1530/reprod/125.6.769. PMID 12773099.
  9. Nicholls PK, Stanton PG, Chen JL, Olcorn JS, Haverfield JT, Qian H, Walton KL, Gregorevic P, Harrison CA (December 2012). "Activin signaling regulates Sertoli cell differentiation and function". Endocrinology. 153 (12): 6065–77. doi:10.1210/en.2012-1821. PMID 23117933.
  10. Rato L, Alves MG, Socorro S, Duarte AI, Cavaco JE, Oliveira PF (May 2012). "Metabolic regulation is important for spermatogenesis". Nature Reviews. Urology. 9 (6): 330–8. doi:10.1038/nrurol.2012.77. PMID 22549313. S2CID 7385545.
  11. Xiong X, Wang A, Liu G, Liu H, Wang C, Xia T, Chen X, Yang K (July 2006). "Effects of p,p'-dichlorodiphenyldichloroethylene on the expressions of transferrin and androgen-binding protein in rat Sertoli cells". Environmental Research. 101 (3): 334–9. Bibcode:2006ER....101..334X. doi:10.1016/j.envres.2005.11.003. PMID 16380112.
  12. Skinner MK, Griswold MD (June 1983). "Sertoli cells synthesize and secrete a ceruloplasmin-like protein". Biology of Reproduction. 28 (5): 1225–1229. doi:10.1095/biolreprod28.5.1225. PMID 6871315.
  13. O'Donnell L, Nicholls PK, O'Bryan MK, McLachlan RI, Stanton PG (January 2011). "Spermiation: The process of sperm release". Spermatogenesis. 1 (1): 14–35. doi:10.4161/spmg.1.1.14525. PMC 3158646. PMID 21866274.
  14. Ahmed EA, Barten-van Rijbroek AD, Kal HB, Sadri-Ardekani H, Mizrak SC, van Pelt AM, de Rooij DG (June 2009). "Proliferative activity in vitro and DNA repair indicate that adult mouse and human Sertoli cells are not terminally differentiated, quiescent cells". Biology of Reproduction. 80 (6): 1084–91. doi:10.1095/biolreprod.108.071662. PMID 19164176.
  15. Walter CA, Intano GW, McCarrey JR, McMahan CA, Walter RB (August 1998). "Mutation frequency declines during spermatogenesis in young mice but increases in old mice". Proceedings of the National Academy of Sciences of the United States of America. 95 (17): 10015–9. Bibcode:1998PNAS...9510015W. doi:10.1073/pnas.95.17.10015. PMC 21453. PMID 9707592.
  16. Dal Secco V, Riccioli A, Padula F, Ziparo E, Filippini A (February 2008). "Mouse Sertoli cells display phenotypical and functional traits of antigen-presenting cells in response to interferon gamma". Biology of Reproduction. 78 (2): 234–42. doi:10.1095/biolreprod.107.063578. PMID 17989360.
  17. Kaur G, Thompson LA, Dufour JM (June 2014). "Sertoli cells--immunological sentinels of spermatogenesis". Seminars in Cell & Developmental Biology. 30: 36–44. doi:10.1016/j.semcdb.2014.02.011. PMC 4043859. PMID 24603046.
  18. Campese AF, Grazioli P, de Cesaris P, Riccioli A, Bellavia D, Pelullo M, Padula F, Noce C, Verkhovskaia S, Filippini A, Latella G, Screpanti I, Ziparo E, Starace D (March 2014). "Mouse Sertoli cells sustain de novo generation of regulatory T cells by triggering the notch pathway through soluble JAGGED1". Biology of Reproduction. 90 (3): 53. doi:10.1095/biolreprod.113.113803. PMID 24478388.
  19. Potempa J, Korzus E, Travis J (June 1994). "The serpin superfamily of proteinase inhibitors: structure, function, and regulation". The Journal of Biological Chemistry. 269 (23): 15957–60. doi:10.1016/S0021-9258(17)33954-6. PMID 8206889.
  20. Lee HM, Oh BC, Lim DP, Lee DS, Lim HG, Park CS, Lee JR (June 2008). "Mechanism of humoral and cellular immune modulation provided by porcine sertoli cells". Journal of Korean Medical Science. 23 (3): 514–20. doi:10.3346/jkms.2008.23.3.514. PMC 2526533. PMID 18583891.
  21. Iliadou PK, Tsametis C, Kaprara A, Papadimas I, Goulis DG (October 2015). "The Sertoli cell: Novel clinical potentiality". Hormones. 14 (4): 504–14. doi:10.14310/horm.2002.1648. PMID 26859601.
  22. Schulz RW, de França LR, Lareyre JJ, Le Gac F, LeGac F, Chiarini-Garcia H, Nobrega RH, Miura T (February 2010). "Spermatogenesis in fish". General and Comparative Endocrinology. 165 (3): 390–411. doi:10.1016/j.ygcen.2009.02.013. PMID 19348807.
  23. Morais RD, Nóbrega RH, Gómez-González NE, Schmidt R, Bogerd J, França LR, Schulz RW (November 2013). "Thyroid hormone stimulates the proliferation of Sertoli cells and single type A spermatogonia in adult zebrafish (Danio rerio) testis". Endocrinology. 154 (11): 4365–76. doi:10.1210/en.2013-1308. PMID 24002037.
  24. Lacerda SM, Costa GM, Campos-Junior PH, Segatelli TM, Yazawa R, Takeuchi Y, Morita T, Yoshizaki G, França LR (February 2013). "Germ cell transplantation as a potential biotechnological approach to fish reproduction". Fish Physiology and Biochemistry. 39 (1): 3–11. doi:10.1007/s10695-012-9606-4. PMID 22290474. S2CID 10134737.
  25. Almeida FF, Kristoffersen C, Taranger GL, Schulz RW (January 2008). "Spermatogenesis in Atlantic cod (Gadus morhua): a novel model of cystic germ cell development". Biology of Reproduction. 78 (1): 27–34. doi:10.1095/biolreprod.107.063669. PMID 17881768.
  26. Mital P, Kaur G, Bowlin B, Paniagua NJ, Korbutt GS, Dufour JM (January 2014). "Nondividing, postpubertal rat Sertoli cells resumed proliferation after transplantation". Biology of Reproduction. 90 (1): 13. doi:10.1095/biolreprod.113.110197. PMC 4076399. PMID 24285718.
  27. Luca G, Arato I, Mancuso F, Calvitti M, Falabella G, Murdolo G, Basta G, Cameron DF, Hansen BC, Fallarino F, Baroni T, Aglietti MC, Tortoioli C, Bodo M, Calafiore R (November 2016). "Xenograft of microencapsulated Sertoli cells restores glucose homeostasis in db/db mice with spontaneous diabetes mellitus". Xenotransplantation. 23 (6): 429–439. doi:10.1111/xen.12274. PMID 27678013. S2CID 46744082.
  28. Valdés-González RA, Dorantes LM, Garibay GN, Bracho-Blanchet E, Mendez AJ, Dávila-Pérez R, Elliott RB, Terán L, White DJ (September 2005). "Xenotransplantation of porcine neonatal islets of Langerhans and Sertoli cells: a 4-year study". European Journal of Endocrinology. 153 (3): 419–27. doi:10.1530/eje.1.01982. PMID 16131605.
  29. Korbutt GS, Elliott JF, Rajotte RV (February 1997). "Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression". Diabetes. 46 (2): 317–22. doi:10.2337/diab.46.2.317. PMID 9000711.
  30. Li Y, Xue W, Liu H, Fan P, Wang X, Ding X, Tian X, Feng X, Pan X, Zheng J, Tian P, Ding C, Fan X (2013-02-20). "Combined strategy of endothelial cells coating, Sertoli cells coculture and infusion improves vascularization and rejection protection of islet graft". PLOS ONE. 8 (2): e56696. Bibcode:2013PLoSO...856696L. doi:10.1371/journal.pone.0056696. PMC 3577699. PMID 23437215.
  31. Bistoni G, Calvitti M, Mancuso F, Arato I, Falabella G, Cucchia R, Fallarino F, Becchetti A, Baroni T, Mazzitelli S, Nastruzzi C, Bodo M, Becchetti E, Cameron DF, Luca G, Calafiore R (July 2012). "Prolongation of skin allograft survival in rats by the transplantation of microencapsulated xenogeneic neonatal porcine Sertoli cells". Biomaterials. 33 (21): 5333–40. doi:10.1016/j.biomaterials.2012.04.020. PMID 22560198.
  32. Hemendinger, Richelle; Wang, Jay; Malik, Saafan; Persinski, Rafal; Copeland, Jane; Emerich, Dwaine; Gores, Paul; Halberstadt, Craig; Rosenfeld, Jeffrey (2005). "Sertoli cells improve survival of motor neurons in SOD1 transgenic mice, a model of amyotrophic lateral sclerosis". Experimental Neurology. 196 (2): 235–243. doi:10.1016/j.expneurol.2005.07.025. PMID 16242126. S2CID 352751.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.